Article citationsMore>>

M. J. Moore, D. D. Von Hoff, T. J. Ervin, F. P. Arena, E. G. Chiorean, et al., “Prognostic Factors (PFs) of Survival in a Randomized Phase III Trial (MPACT) of Weekly Nab-paclitaxel (nab-P) plus Gemcitabine (G) versus G alone in Patients (pts) with Metastatic Pancreatic Cancer (MPC),” Journal of Clinical Oncology, Vol. 31, Suppl. 4059, 2013.

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top